Publication: 2498

Publication: 2498

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B trial 9342.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 22 (11) 2061-8

Year:: 2004
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: CA03927, CA04457, CA07968, CA12046, CA21060, CA32291, CA33601, CA41287, CA47559, CA47577, CA60138, CA77406, CA77651

Corr. Author:
Authors:: Eric P Winer Donald A Berry Susan Woolf David Duggan Alice Kornblith Lyndsay N Harris Richard A Michaelson Jeffrey A Kirshner Gini F Fleming Michael C Perry Mark L Graham Stewart A Sharp Roger Keresztes I Craig Henderson Clifford Hudis Hyman Muss Larry Norton

Networks:

Study: CALGB-9342
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adult, Antineoplastic Agents, Phytogenic, Breast Neoplasms, Disease-Free Survival, Dose-Response Relationship, Drug, Female, Humans, Logistic Models, Multivariate Analysis, Paclitaxel, Quality of Life, Survival Rate, Treatment Failure, United States